Abliva AB (OSTO:ABLI) Stock Based Compensation : kr1.29 Mil (TTM As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Abliva AB Stock Based Compensation?

Abliva AB's Stock Based Compensation for the three months ended in Mar. 2024 was kr0.28 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was kr1.29 Mil.

Abliva AB Stock Based Compensation Historical Data

The historical data trend for Abliva AB's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abliva AB Stock Based Compensation Chart

Abliva AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Stock Based Compensation

Get a 7-Day Free Trial

0.42

0.55

1.22

Abliva AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Stock Based Compensation	Get a 7-Day Free Trial															0.22	0.35	0.33	0.33	0.28

Abliva AB Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.29 Mil.

Abliva AB Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Abliva AB's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Abliva AB (OSTO:ABLI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abliva AB (OSTO:ABLI) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

NEVPF:USA NTP:Germany

Address

Scheeletorget 1, Medicon Village, Lund, SWE, 223 81

Website

https://www.abliva.com

Abliva AB is a Swedish company that is active in pharmaceutical development. It develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare, and often very severe diseases occur when the cell's energy provider, the mitochondria, does not function properly. The portfolio includes projects at different stages and ranges from the early discovery phase to the clinical phase.

Abliva AB (OSTO:ABLI) Headlines

No Headlines